We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GURE
3201
Gulf Resources
GURE
$4.62M
$2K ﹤0.01%
+25
New +$2.01K
HFXI icon
3202
NYLI FTSE International Equity Currency Neutral ETF
HFXI
$2.05B
$2K ﹤0.01%
+95
New +$2.03K
HOV icon
3203
Hovnanian Enterprises
HOV
$764M
$2K ﹤0.01%
+20
New +$1.24K
HPS
3204
John Hancock Preferred Income Fund III
HPS
$458M
$2K ﹤0.01%
+100
New +$1.85K
HQL
3205
abrdn Life Sciences Investors
HQL
$586M
$2K ﹤0.01%
98
-842
-90% -$16.9K
HRTX icon
3206
Heron Therapeutics
HRTX
$96.8M
$2K ﹤0.01%
101
-5,403
-98% -$88.1K
HYT icon
3207
BlackRock Corporate High Yield Fund
HYT
$1.36B
$2K ﹤0.01%
+160
New +$1.78K
IMAX icon
3208
IMAX
IMAX
$2.8B
$2K ﹤0.01%
98
-6,785
-99% -$160K
INVE icon
3209
Identive
INVE
$64.8M
$2K ﹤0.01%
468
-520
-53% -$1.82K
INVH icon
3210
Invitation Homes
INVH
$18.1B
$2K ﹤0.01%
100
-14,710
-99% -$341K
IRM icon
3211
Iron Mountain
IRM
$37.3B
$2K ﹤0.01%
50
-253
-83% -$10K
ISSC icon
3212
Innovative Solutions & Support
ISSC
$348M
$2K ﹤0.01%
+551
New +$1.74K
JKS
3213
JinkoSolar
JKS
$837M
$2K ﹤0.01%
+100
New +$2.52K
JRI icon
3214
Nuveen Real Asset Income & Growth Fund
JRI
$352M
$2K ﹤0.01%
+100
New +$1.77K
OPLN
3215
Openlane
OPLN
$4.36B
$2K ﹤0.01%
+111
New +$2.06K
KBH icon
3216
KB Home
KBH
$3.56B
$2K ﹤0.01%
73
-9,954
-99% -$286K
KEQU icon
3217
Kewaunee Scientific
KEQU
$107M
$2K ﹤0.01%
+68
New +$1.96K
KRG icon
3218
Kite Realty
KRG
$5.69B
$2K ﹤0.01%
100
-10,380
-99% -$202K
LRFC
3219
DELISTED
Logan Ridge Finance Corp
LRFC
$2K ﹤0.01%
42
+40
+2,000% +$1.95K
LXRX icon
3220
Lexicon Pharmaceuticals
LXRX
$1.03B
$2K ﹤0.01%
191
-3,152
-94% -$32.8K
MAA icon
3221
Mid-America Apartment Communities
MAA
$15.5B
$2K ﹤0.01%
21
-32
-60% -$3.32K
MD icon
3222
Pediatrix Medical
MD
$2.16B
$2K ﹤0.01%
38
-524
-93% -$24.7K
MDXG icon
3223
MiMedx Group
MDXG
$622M
$2K ﹤0.01%
154
-6,079
-98% -$74.1K
MYND
3224
Mynd.ai
MYND
$18.9M
$2K ﹤0.01%
+10
New +$2.35K
NI icon
3225
NiSource
NI
$21.3B
$2K ﹤0.01%
60
-128
-68% -$3.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.